Works by Umeyama, Yoshiko

Results: 21

Evaluation of the Association of Polymorphisms With Palbociclib‐Induced Neutropenia: Pharmacogenetic Analysis of PALOMA‐2/‐3.

Published in:

Oncologist, 2021, v. 26, n. 7, p. e1143, doi. 10.1002/onco.13811

By:

Iwata, Hiroji;
Umeyama, Yoshiko;
Liu, Yuan;
Zhang, Zhe;
Schnell, Patrick;
Mori, Yuko;
Fletcher, Olivia;
Marshall, Jean‐Claude;
Johnson, Jillian G.;
Wood, Linda S.;
Toi, Masakazu;
Finn, Richard S.;
Turner, Nicholas C.;
Bartlett, Cynthia Huang;
Cristofanilli, Massimo

Publication type:

Article

Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 249, doi. 10.1159/000514420

By:

Kudo, Masatoshi;
Motomura, Kenta;
Wada, Yoshiyuki;
Inaba, Yoshitaka;
Sakamoto, Yasunari;
Kurosaki, Masayuki;
Umeyama, Yoshiko;
Kamei, Yoichi;
Yoshimitsu, Junichiro;
Fujii, Yosuke;
Aizawa, Mana;
Robbins, Paul B.;
Furuse, Junji

Publication type:

Article

Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3.

Published in:

Breast Cancer (13406868), 2021, v. 28, n. 2, p. 335, doi. 10.1007/s12282-020-01162-4

By:

Masuda, Norikazu;
Mukai, Hirofumi;
Inoue, Kenichi;
Rai, Yoshiaki;
Ohno, Shinji;
Ohtani, Shoichiro;
Shimizu, Chikako;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Umeyama, Yoshiko;
Iwata, Hiroji;
Toi, Masakazu

Publication type:

Article

Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Published in:

2019

By:

Masuda, Norikazu;
Mukai, Hirofumi;
Inoue, Kenichi;
Rai, Yoshiaki;
Ohno, Shinji;
Mori, Yuko;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Umeyama, Yoshiko;
Iwata, Hiroji;
Toi, Masakazu

Publication type:

Correction Notice

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Published in:

Breast Cancer (13406868), 2019, v. 26, n. 5, p. 637, doi. 10.1007/s12282-019-00970-7

By:

Masuda, Norikazu;
Mukai, Hirofumi;
Inoue, Kenichi;
Rai, Yoshiaki;
Ohno, Shinji;
Mori, Yuko;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Umeyama, Yoshiko;
Iwata, Hiroji;
Toi, Masakuzu

Publication type:

Article

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.

Published in:

Cancer Science, 2020, v. 111, n. 3, p. 907, doi. 10.1111/cas.14294

By:

Uemura, Motohide;
Tomita, Yoshihiko;
Miyake, Hideaki;
Hatakeyama, Shingo;
Kanayama, Hiro‐omi;
Numakura, Kazuyuki;
Takagi, Toshio;
Kato, Tomoyuki;
Eto, Masatoshi;
Obara, Wataru;
Uemura, Hirotsugu;
Choueiri, Toni K.;
Motzer, Robert J.;
Fujii, Yosuke;
Kamei, Yoichi;
Umeyama, Yoshiko;
Pietro, Alessandra;
Oya, Mototsugu

Publication type:

Article

Palbociclib in combination with letrozole as first‐line treatment for advanced breast cancer: A Japanese phase II study.

Published in:

Cancer Science, 2018, v. 109, n. 3, p. 803, doi. 10.1111/cas.13507

By:

Masuda, Norikazu;
Nishimura, Reiki;
Takahashi, Masato;
Inoue, Kenichi;
Ohno, Shinji;
Iwata, Hiroji;
Mori, Yuko;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Nagasawa, Takashi;
Umeyama, Yoshiko;
Toi, Masakazu

Publication type:

Article

Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study.

Published in:

Cancer Science, 2017, v. 108, n. 6, p. 1231, doi. 10.1111/cas.13232

By:

Oya, Mototsugu;
Tomita, Yoshihiko;
Fukasawa, Satoshi;
Shinohara, Nobuo;
Habuchi, Tomonori;
Rini, Brian I.;
Fujii, Yosuke;
Kamei, Yoichi;
Umeyama, Yoshiko;
Bair, Angel H.;
Uemura, Hirotsugu

Publication type:

Article

Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients.

Published in:

Cancer Science, 2016, v. 107, n. 6, p. 755, doi. 10.1111/cas.12932

By:

Tamura, Kenji;
Mukai, Hirofumi;
Naito, Yoichi;
Yonemori, Kan;
Kodaira, Makoto;
Tanabe, Yuko;
Yamamoto, Noboru;
Osera, Shozo;
Sasaki, Masaoki;
Mori, Yuko;
Hashigaki, Satoshi;
Nagasawa, Takashi;
Umeyama, Yoshiko;
Yoshino, Takayuki

Publication type:

Article

Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma.

Published in:

Cancer Science, 2014, v. 105, n. 12, p. 1576, doi. 10.1111/cas.12546

By:

Eto, Masatoshi;
Uemura, Hirotsugu;
Tomita, Yoshihiko;
Kanayama, Hiroomi;
Shinohara, Nobuo;
Kamei, Yoichi;
Fujii, Yosuke;
Umeyama, Yoshiko;
Ozono, Seiichiro;
Naito, Seiji;
Akaza, Hideyuki

Publication type:

Article

Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers: A phase I study in Japanese patients.

Published in:

Cancer Science, 2010, v. 101, n. 4, p. 963, doi. 10.1111/j.1349-7006.2009.01465.x

By:

Mukohara, Toru;
Nakajima, Hikaru;
Mukai, Hirofumi;
Nagai, Shunji;
Itoh, Kuniaki;
Umeyama, Yoshiko;
Hashimoto, Junichi;
Minami, Hironobu

Publication type:

Article

Palbociclib‐letrozole as first‐line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study.

Published in:

Cancer Medicine, 2020, v. 9, n. 14, p. 4929, doi. 10.1002/cam4.3091

By:

Takahashi, Masato;
Masuda, Norikazu;
Nishimura, Reiki;
Inoue, Kenichi;
Ohno, Shinji;
Iwata, Hiroji;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Umeyama, Yoshiko;
Toi, Masakazu

Publication type:

Article

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 262, doi. 10.1007/s10147-018-1359-3

By:

Masuda, Norikazu;
Inoue, Kenichi;
Nakamura, Rikiya;
Rai, Yoshiaki;
Mukai, Hirofumi;
Ohno, Shinji;
Hara, Fumikata;
Mori, Yuko;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Nagasawa, Takashi;
Umeyama, Yoshiko;
Huang, Xin;
Iwata, Hiroji

Publication type:

Article

Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 274, doi. 10.1007/s10147-018-1353-9

By:

Mukai, Hirofumi;
Shimizu, Chikako;
Masuda, Norikazu;
Ohtani, Shoichiro;
Ohno, Shinji;
Takahashi, Masato;
Yamamoto, Yutaka;
Nishimura, Reiki;
Sato, Nobuaki;
Ohsumi, Shozo;
Iwata, Hiroji;
Mori, Yuko;
Hashigaki, Satoshi;
Muramatsu, Yasuaki;
Nagasawa, Takashi;
Umeyama, Yoshiko;
Lu, Dongrui R.;
Toi, Masakazu

Publication type:

Article

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study.

Published in:

2019

By:

Tomita, Yoshihiko;
Uemura, Hirotsugu;
Oya, Mototsugu;
Shinohara, Nobuo;
Habuchi, Tomonori;
Fujii, Yosuke;
Kamei, Yoichi;
Umeyama, Yoshiko;
Bair, Angel H;
Rini, Brian I

Publication type:

journal article

Axitinib plasma pharmacokinetics and ethnic differences.

Published in:

Investigational New Drugs, 2015, v. 33, n. 2, p. 521, doi. 10.1007/s10637-015-0214-x

By:

Chen, Ying;
Suzuki, Akiyuki;
Tortorici, Michael;
Garrett, May;
LaBadie, Robert;
Umeyama, Yoshiko;
Pithavala, Yazdi

Publication type:

Article

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.

Published in:

Investigational New Drugs, 2012, v. 30, n. 3, p. 1055, doi. 10.1007/s10637-011-9637-1

By:

Fujiwara, Yutaka;
Kiyota, Naomi;
Chayahara, Naoko;
Suzuki, Akiyuki;
Umeyama, Yoshiko;
Mukohara, Toru;
Minami, Hironobu

Publication type:

Article

Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First‐Line Treatment in Patients With Metastatic Castration‐Resistant Prostate Cancer: TALAPRO‐2 Japanese Subgroup Analysis.

Published in:

Cancer Medicine, 2025, v. 14, n. 1, p. 1, doi. 10.1002/cam4.70333

By:

Matsubara, Nobuaki;
Miyake, Hideaki;
Uemura, Hiroji;
Mizokami, Atsushi;
Kikukawa, Hiroaki;
Kosaka, Takeo;
Nishimura, Kazuo;
Nakamura, Motonobu;
Kobayashi, Kazuki;
Komaru, Atsushi;
Mori, Yuko;
Toyoizumi, Shigeyuki;
Hori, Natsuki;
Umeyama, Yoshiko;
Uemura, Hirotsugu

Publication type:

Article

Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial.

Published in:

Japanese Journal of Clinical Oncology, 2015, v. 45, n. 5, p. 439, doi. 10.1093/jjco/hyv011

By:

Tatsuya Ioka;
Takuji Okusaka;
Shinichi Ohkawa;
Narikazu Boku;
Akira Sawaki;
Yosuke Fujii;
Yoichi Kamei;
Satori Takahashi;
Katsushi Namazu;
Yoshiko Umeyama;
Bycott, Paul;
Junji Furuse

Publication type:

Article

Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 study.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 72, doi. 10.1007/s10147-024-02648-3

By:

Iwata, Hiroji;
Naito, Yoichi;
Hattori, Masaya;
Yoshimura, Akiyo;
Yonemori, Kan;
Aizawa, Mana;
Mori, Yuko;
Yoshimitsu, Junichiro;
Umeyama, Yoshiko;
Mukohara, Toru

Publication type:

Article

Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis.

Published in:

International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 383, doi. 10.1007/s10147-021-02067-8

By:

Tomita, Yoshihiko;
Yamamoto, Yoshiaki;
Tsuchiya, Norihiko;
Kanayama, Hiroomi;
Eto, Masatoshi;
Miyake, Hideaki;
Powles, Thomas;
Yoshida, Mizuki;
Koide, Yuichiro;
Umeyama, Yoshiko;
di Pietro, Alessandra;
Uemura, Hirotsugu

Publication type:

Article